3 weeks ago

Decipher Prostate is the first and only genomic test recognized by eviCore for the management...

Company

4 weeks ago

Decipher Biosciences Achieves Major Medicare Milestone with Expansion in Coverage for Decipher Prostate Genomic Testing...

Research

Decipher Identifies a Molecular Subtype Most Likely to Benefit from Neoadjuvant KEYTRUDA Immunotherapy in Bladder Cancer Patients

6 months ago

Decipher Biosciences, a commercial-stage precision oncology company committed to improving patient care, initially focused on...

Company

NCCN Guidelines Designate Decipher Prostate as “Recommended” for Men with Adverse Pathology after Radical Prostatectomy

7 months ago

Decipher Biosciences, a commercial-stage precision oncology company committed to improving patient care, initially focused on...

Research

Decipher Prostate RP Identifies Patients Likely to Benefit from Hormonal Therapy in Men with Recurrent Prostate Cancer

8 months ago

Decipher Biosciences, a commercial-stage precision oncology company committed to improving patient care, initially focused on...

Research

Decipher GRID Signature Predicts Benefit from Chemotherapy in Men Diagnosed with Metastatic Prostate Cancer

8 months ago

Decipher Biosciences, a commercial-stage precision oncology company committed to improving patient care, initially focused on...

Company

Decipher Biosciences Announces Addition of Dr. Robert S. Epstein as Chairman and Kathy Hibbs, Esq. to its Board of Directors

9 months ago

Decipher Biosciences, a commercial-stage precision oncology company committed to improving patient care, initially focused on...

Research

Decipher Biosciences Announces Publication of a Prospective Clinical Study Demonstrating that the Use of Decipher Prostate RP Guides Post-Operative Management Decisions and Improves Patient Outcomes

10 months ago

Decipher Biosciences, a commercial stage precision oncology company initially focused on urologic cancers, today announced...